Announced Tue, 26 May · 17:33 IST

Procter & Gamble Health Limited has informed the Exchange regarding re-appointment of Mr. S. Madhavan as Non- Executive Independent Director of the company w.e.f. November 15, 2026.

Management Changes View source PDF

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.1%1-day move
₹5662.00
prior close
₹5949.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+5.5+10.0+6.5+6.1+6.7+6.2+7.7+9.2+9.1+11.5+10.5+19.9
Up moveDown movePending
AI summary

Procter & Gamble Health Limited has announced the re-appointment of Mr. S. Madhavan as Non-Executive Independent Director for a second term of five years, effective November 15, 2026. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. The company has confirmed that Mr. Madhavan meets all independence criteria under the Companies Act, 2013 and SEBI regulations. He does not hold any shares in the company and has no related party connections with other directors.

Likely market impact

This is a routine corporate governance update with minimal direct impact on stock price. Shareholders will vote on this re-appointment, which strengthens board continuity and independence.